Published in Biochim Biophys Acta on March 08, 1982
Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol Sci (1989) 4.41
Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate. Proc Natl Acad Sci U S A (1973) 3.91
Structural model for the beta-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide. Nat Struct Biol (1995) 3.44
The relation between intercellular coupling and electrical noise in turtle photoreceptors. J Physiol (1976) 2.76
Colour-dependence of cone responses in the turtle retina. J Physiol (1973) 2.71
Analysis of electrical noise in turtle cones. J Physiol (1977) 2.38
Two types of luminosity horizontal cells in the retina of the turtle. J Physiol (1973) 2.31
Spontaneous voltage fluctuations in retinal cones and bipolar cells. Nature (1975) 2.05
The acetylcholine receptor. I. Purification and characterization of a macromolecule isolated from Electrophorus electricus. J Biol Chem (1973) 1.75
Reductive cleavage of cystine disulfides with tributylphosphine. Methods Enzymol (1977) 1.68
Further properties of stereospecific opiate binding sites in rat brain: on the nature of the sodium effect. J Pharmacol Exp Ther (1975) 1.68
A human cellular model for studying the regulation of glucagon-like peptide-1 secretion. Endocrinology (2001) 1.56
Acetylcholine receptor and myasthenia gravis. Ann N Y Acad Sci (1976) 1.54
Stereoselectivity at the calcium channel: opposite action of the enantiomers of a 1,4-dihydropyridine. J Cardiovasc Pharmacol (1985) 1.49
Interactions leading to horizontal cell responses in the turtle retina. J Physiol (1974) 1.41
Distribution of stereospecific binding of the potent narcotic analgesic etorphine in the human brain: predominance in the limbic system. Res Commun Chem Pathol Pharmacol (1973) 1.36
Polyamines and inhibition of RNA synthesis in E. coli by levorphanol. Biochem Biophys Res Commun (1966) 1.34
Evidence from opiate binding studies that heroin acts through its metabolites. Life Sci (1983) 1.30
Studies on the intracellular distribution and tissue binding of dihydromorphine-7,8-H3 in the rat. Proc Soc Exp Biol Med (1966) 1.30
Acetylcholine receptor. Responses to drug binding. J Biol Chem (1977) 1.29
Coupling of a new, active morphine derivative to sepharose for affinity chromatography. Proc Natl Acad Sci U S A (1972) 1.29
Effects of levorphanol on phospholipid metabolism and composition in Escherichia coli. Biochim Biophys Acta (1971) 1.28
Human lymphoblastoid interferon. Large scale production and partial purification. J Biol Chem (1977) 1.24
A radioimmunoassay for the quantitative evaluation of anti-human acetylcholine receptor antibodies in myasthenia gravis. Clin Exp Immunol (1977) 1.23
POLTERGEIST functions to regulate meristem development downstream of the CLAVATA loci. Development (2000) 1.21
Properties of centre-hyperpolarizing, red-sensitive bipolar cells in the turtle retina. J Physiol (1975) 1.16
Potential affinity labels for the opiate receptor based on fentanyl and related compounds. J Med Chem (1982) 1.16
Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients. Brain Res (2001) 1.15
A rapid and sensitive assay for arginase. Anal Biochem (1980) 1.13
Kinetics of opiate receptor inactivation by sulfhydryl reagents: evidence for conformational change in presence of sodium ions. Proc Natl Acad Sci U S A (1975) 1.11
Receptor affinity and pharmacological potency of a series of narcotic analgesic, anti-diarrheal and neuroleptic drugs. Eur J Pharmacol (1977) 1.10
The effects of the morphine analogue levorphanol on leukocytes. Metabolic effects at rest and during phagocytosis. J Clin Invest (1971) 1.10
Denervation of newborn rat muscle does not block the appearance of adult fast myosin heavy chain. Nature (1982) 1.08
Solubilization of a stereospecific opiate-macromolecular complex from rat brain. Science (1975) 1.08
3H-ethylketocyclazocine binding: lack of evidence for a separate kappa receptor in rats CNS. Eur J Pharmacol (1979) 1.07
Specific, high affinity [3H]ethylketocyclazocine binding in rat central nervous system: lack of evidence for kappa receptors. J Pharmacol Exp Ther (1980) 1.07
Regulation of cytosolic calcium in skeletal muscle cells of the mdx mouse under conditions of stress. Br J Pharmacol (1996) 1.05
Selective protection of stereospecific enkephalin and opiate binding against inactivation by N-ethylmaleimide: evidence for two classes of opiate receptors. Proc Natl Acad Sci U S A (1980) 1.04
Effect of levorphanol on putrescine transport in Escherichia coli. Mol Pharmacol (1970) 1.04
Electrical responses of double cones in the turtle retina. J Physiol (1974) 1.03
Vasopressin induced production of inositol trisphosphate and calcium efflux in a smooth muscle cell line. Biochem Biophys Res Commun (1985) 1.03
A monoclonal anti-idiotypic antibody against anti-receptor antibodies from myasthenic sera. Eur J Immunol (1982) 1.02
Comparative studies on synaptosomes: uptake of (N-Me-3H)choline by synaptosomes from squid optic lobes. J Neurochem (1973) 0.99
Lack of evidence for voltage dependent calcium channels on platelets. Biochem Biophys Res Commun (1985) 0.97
Purification of an active opioid-binding protein from bovine striatum. J Biol Chem (1985) 0.97
Solubilization of an active opiate receptor from Bufo marinus. Eur J Pharmacol (1980) 0.97
Antibodies from myasthenic patients that compete with cholinergic agents for binding to nicotinic receptors. Proc Natl Acad Sci U S A (1980) 0.96
Covalent labeling of opioid receptors with radioiodinated human beta-endorphin. Identification of binding site subunit. J Biol Chem (1985) 0.96
Experimental myasthenia in Balb/c mice immunized with rat acetylcholine receptor from rat denervated muscle. Proc Natl Acad Sci U S A (1976) 0.96
Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC. J Neurochem (1999) 0.95
mu and delta-opioid receptor agonists induce mitogen-activated protein kinase (MAPK) activation in the absence of receptor internalization. Neuropharmacology (2000) 0.95
Studies on the mechanism of action of the vasoconstrictive dihydropyridine, CGP 28392. Eur J Pharmacol (1984) 0.93
Opiate receptors and their interactions with agnoists and antagonists. Life Sci (1975) 0.93
Properties and serum levels of specific populations of anti-acetylcholine receptor antibodies in myasthenia gravis. Ann N Y Acad Sci (1981) 0.93
Growth of dissociated neurons in culture dishes coated with synthetic polymeric amines. Neurosci Lett (1984) 0.93
Solubilization and characterization of active opiate binding sites from mammalian brain. J Pharmacol Exp Ther (1982) 0.92
Intrathymic pathogenesis of myasthenia gravis: transient expression of acetylcholine receptors on thymus-derived myogenic cells. Eur J Immunol (1978) 0.91
Tyrosine phosphorylation of the delta-opioid receptor. Evidence for its role in mitogen-activated protein kinase activation and receptor internalization*. Biochem Pharmacol (2000) 0.91
Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: possible lack of relationship to immunosuppressive activity. Br J Pharmacol (1996) 0.91
Ontological development of opiate receptors in rodent brain. Brain Res (1976) 0.90
Solubilization and characterization of mu, delta, and kappa opioid binding sites from guinea pig brain: physical separation of kappa receptors. Proc Natl Acad Sci U S A (1984) 0.90
Calcium influx inhibition by steroids and analogs in C2C12 skeletal muscle cells. Br J Pharmacol (1998) 0.90
Sodium ions increase the binding of the antagonist peptide ICI 174864 to the delta-opiate receptor. Neuropeptides (1986) 0.90
Monoclonal antibodies directed against the neurotransmitter binding site of nicotinic acetylcholine receptor. FEBS Lett (1980) 0.89
Multiple opiate receptors: alcohol selectively inhibits binding to delta receptors. Science (1981) 0.89
Metabolism of polyamines in mouse neuroblastoma cells in culture: formation of GABA and putreanine. J Neurochem (1975) 0.89
Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells. FEBS Lett (1998) 0.89
Cyclosporin A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells. Biochem J (1987) 0.87
The opiate receptors. Annu Rev Pharmacol Toxicol (1978) 0.87
Modulation by prednisolone of calcium handling in skeletal muscle cells. Br J Pharmacol (1995) 0.87
Increase of empty pool-activated Ca2+ influx using an intracellular Ca2+ chelating agent. Biochem Biophys Res Commun (1996) 0.87
Identification of a neurorestrictive suppressor element (NRSE) in the human mu-opioid receptor gene. Brain Res Mol Brain Res (2001) 0.87
Evidence for the presence of disulfide bridges in opioid receptors essential for ligand binding. Possible role in receptor activation. J Mol Recognit (1989) 0.87
Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: I. PKC translocation to the membrane of SH-SY5Y neuroblastoma cells is induced by mu-opioid agonists. J Neurochem (1999) 0.86
Differential blockade of agonist- and depolarization-induced 45Ca2+ influx in smooth muscle cells. Am J Physiol (1989) 0.86
Mutation of tyrosine 318 (Y318F) in the delta-opioid receptor attenuates tyrosine phosphorylation, agonist-dependent receptor internalization, and mitogen-activated protein kinase activation. Brain Res Mol Brain Res (2000) 0.86
Serotonin increases the production of inositol phosphates and mobilises calcium via the 5-HT2 receptor in A7r5 smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.85
The effect of the morphine analog levorphanol on phagocytosing leukocytes. A morphologic study. Lab Invest (1971) 0.85
Power spectral measurements of noise in the turtle tetina [proceedings]. J Physiol (1976) 0.85
Alkylation of cysteine thiols with 1,3-propane sultone. Methods Enzymol (1977) 0.85
Opiate receptors in cultures of fetal mouse dorsal root ganglia (DRG) and spinal cord: predominance in DRG neurites. Brain Res (1978) 0.85
Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex. J Pharmacol Exp Ther (1990) 0.84
Antibodies to acetylcholine receptor in patients with thymoma but without myasthenia gravis. Neurology (1980) 0.84
Phospholipase A inhibition of opiate receptor binding can be reversed by albumin. Nature (1978) 0.84
Initiation of chains by RNA polymerase and the effects of inhibitors studied by a direct filtration technique. Biochim Biophys Acta (1968) 0.84
Localization of promoter elements in the human mu-opioid receptor gene and regulation by DNA methylation. Brain Res Mol Brain Res (1999) 0.83
Cyclosporin A potentiates receptor-activated [Ca2+]c increase. J Recept Signal Transduct Res (1997) 0.83
Study of two different subpopulations of anti-acetylcholine receptor antibodies in a rabbit with experimental auto-immune myasthenia gravis. Eur J Immunol (1977) 0.83
Increased uptake of acetylcholine-receptor antibody at motor endplate in myasthenic exacerbation. Lancet (1978) 0.83
Central nervous-system involvement in experimental autoimmune myasthenia gravis. Lancet (1977) 0.83
Binding properties and subclass distribution of anti-acetylcholine receptor antibodies in myasthenia gravis. J Neuroimmunol (1981) 0.83
Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients. Brain Res (1987) 0.83
Characterization and partial purification of solubilized active opiate receptors from toad brain. Proc Natl Acad Sci U S A (1981) 0.83
[Antibodies against nicotine-like acetylcholine receptors of central nervous system and muscles in epileptics with IgA deficiency]. Schweiz Med Wochenschr (1978) 0.83